Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

This report describes the pharmacokinetics of colistin methanesulfonate (CMS) and colistin in five intensive care unit patients receiving continuous venovenous hemodiafiltration. For CMS, the mean maximum concentration of drug in plasma (C(max)) after the fourth dose was 6.92 mg/liter and total clea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Karvanen, Matti, Plachouras, Diamantis, Friberg, Lena E., Paramythiotou, Elisabeth, Papadomichelakis, Evangelos, Karaiskos, Ilias, Tsangaris, Iraklis, Armaganidis, Apostolos, Cars, Otto, Giamarellou, Helen
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2013
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535942/
https://ncbi.nlm.nih.gov/pubmed/23147733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00985-12
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares